hafren scientific ltd

Live EstablishedSmallHealthy

hafren scientific ltd Company Information

Share HAFREN SCIENTIFIC LTD

Company Number

06769895

Directors

Carol Bell

Victoria Ridge

View All

Shareholders

timothy pearce

john martin

View All

Group Structure

View All

Industry

Activities of head offices

 

Registered Address

unit 1 ravencroft court, buttington enterprise park butti, welshpool, powys, SY21 8SL

hafren scientific ltd Estimated Valuation

£2m

Pomanda estimates the enterprise value of HAFREN SCIENTIFIC LTD at £2m based on a Turnover of £3.3m and 0.62x industry multiple (adjusted for size and gross margin).

hafren scientific ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of HAFREN SCIENTIFIC LTD at £0 based on an EBITDA of £-11k and a 4.74x industry multiple (adjusted for size and gross margin).

hafren scientific ltd Estimated Valuation

£2.1m

Pomanda estimates the enterprise value of HAFREN SCIENTIFIC LTD at £2.1m based on Net Assets of £1.1m and 1.99x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Hafren Scientific Ltd Overview

Hafren Scientific Ltd is a live company located in welshpool, SY21 8SL with a Companies House number of 06769895. It operates in the activities of head offices sector, SIC Code 70100. Founded in December 2008, it's largest shareholder is timothy pearce with a 60% stake. Hafren Scientific Ltd is a established, small sized company, Pomanda has estimated its turnover at £3.3m with healthy growth in recent years.

View Sample
View Sample
View Sample

Hafren Scientific Ltd Health Check

Pomanda's financial health check has awarded Hafren Scientific Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

4 Strong

positive_score

1 Regular

positive_score

6 Weak

size

Size

annual sales of £3.3m, make it smaller than the average company (£20.2m)

£3.3m - Hafren Scientific Ltd

£20.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 6%, show it is growing at a slower rate (7.3%)

6% - Hafren Scientific Ltd

7.3% - Industry AVG

production

Production

with a gross margin of 46%, this company has a lower cost of product (33.7%)

46% - Hafren Scientific Ltd

33.7% - Industry AVG

profitability

Profitability

an operating margin of -7.7% make it less profitable than the average company (5.8%)

-7.7% - Hafren Scientific Ltd

5.8% - Industry AVG

employees

Employees

with 55 employees, this is below the industry average (110)

55 - Hafren Scientific Ltd

110 - Industry AVG

paystructure

Pay Structure

on an average salary of £36.3k, the company has a lower pay structure (£49.9k)

£36.3k - Hafren Scientific Ltd

£49.9k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £60k, this is less efficient (£204.5k)

£60k - Hafren Scientific Ltd

£204.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 57 days, this is later than average (45 days)

57 days - Hafren Scientific Ltd

45 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 38 days, this is close to average (42 days)

38 days - Hafren Scientific Ltd

42 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Hafren Scientific Ltd

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 23 weeks, this is more cash available to meet short term requirements (15 weeks)

23 weeks - Hafren Scientific Ltd

15 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 49.3%, this is a lower level of debt than the average (55.7%)

49.3% - Hafren Scientific Ltd

55.7% - Industry AVG

HAFREN SCIENTIFIC LTD financials

EXPORTms excel logo

Hafren Scientific Ltd's latest turnover from December 2023 is £3.3 million and the company has net assets of £1.1 million. According to their latest financial statements, Hafren Scientific Ltd has 55 employees and maintains cash reserves of £307.9 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Aug 2015Aug 2014Aug 2013Aug 2012Aug 2011Aug 2010Aug 2009
Turnover3,300,8903,848,6282,731,8392,806,6226,237,2284,652,4294,261,6164,250,6485,657,7586,202,2495,420,7084,475,4653,692,9192,191,485
Other Income Or Grants
Cost Of Sales1,783,7572,049,3991,793,1832,054,3352,608,0662,182,4221,674,7882,461,1742,741,4212,657,6022,245,5512,118,4931,915,5561,517,963
Gross Profit1,517,1331,799,229938,656752,2873,629,1622,470,0072,586,8281,789,4742,916,3373,544,6473,175,1572,356,9721,777,363673,521
Admin Expenses1,771,9652,024,6021,711,3081,603,6272,943,7652,365,7062,403,1793,068,7263,155,4873,012,9542,392,0471,684,1681,039,660652,067-54,864
Operating Profit-254,832-225,373-772,652-851,340685,397104,301183,649-1,279,252-239,150531,693783,110672,804737,70321,45454,864
Interest Payable51,02048,55022,97149,13741,65638,31343,90445,27729,280518372,2341,341
Interest Receivable24420,5451,439296519206951,37963622574729619214996
Pre-Tax Profit-339,007-226,785-776,438-897,256608,90383,251122,452-1,275,995-267,794531,400783,820670,866736,55421,60354,960
Tax104,27288,455219,89598,980-20,360219,32125,801194,177317,017-148,175-172,068-264,248-242,615-6,049-15,389
Profit After Tax-234,735-138,330-556,543-798,276588,543302,572148,253-1,081,81849,223383,225611,752406,618493,93915,55439,571
Dividends Paid20,00020,00022,10066,300
Retained Profit-234,735-138,330-556,543-798,276588,543302,572148,253-1,081,81849,223363,225591,752384,518427,63915,55439,571
Employee Costs1,993,9962,206,2202,028,0522,446,0482,696,5182,349,5811,958,1472,868,7623,137,0772,611,6582,042,4431,022,735874,032530,311
Number Of Employees5558586967584855857236302616
EBITDA*-10,96850,205-550,012-564,5721,305,997457,313554,199-1,036,494278,039894,4861,006,370860,419787,68272,750229,616

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Aug 2015Aug 2014Aug 2013Aug 2012Aug 2011Aug 2010Aug 2009
Tangible Assets653,663783,107627,274781,848890,581638,516784,7481,039,4701,245,4351,011,867534,291353,473388,099220,029223,756
Intangible Assets89,549124,089158,629231,814280,391221,963216,046219,021306,623317,680235,560234,353128,823
Investments & Other16,9085,0015,001710100
Debtors (Due After 1 year)
Total Fixed Assets743,212924,104785,9031,013,6621,170,972865,4801,005,7951,258,4911,552,0581,329,547769,851587,826516,922220,739223,856
Stock & work in progress
Trade Debtors517,6191,054,871929,328529,6011,613,6551,930,9121,449,869978,9501,011,9781,578,5571,522,407763,621871,364281,642106,973
Group Debtors85,42931,50841,87641,58841,53127,260
Misc Debtors425,557444,659439,576588,081739,035479,611303,311249,862585,319295,981112,510269,064101,453
Cash307,899329,715665,4911,342,0311,395,834583,367413,945400,410824,065379,970968,9271,227,482913,14521,20538,436
misc current assets
total current assets1,336,5041,860,7532,076,2712,501,3013,790,0553,021,1502,167,1251,629,2222,421,3622,254,5082,603,8442,260,1671,885,962302,847145,409
total assets2,079,7162,784,8572,862,1743,514,9634,961,0273,886,6303,172,9202,887,7133,973,4203,584,0553,373,6952,847,9932,402,884523,586369,265
Bank overdraft
Bank loan
Trade Creditors 187,269249,424159,465177,811177,878286,190238,448190,075127,585364,841263,538247,709475,329436,107292,346
Group/Directors Accounts
other short term finances126,586143,180159,155142,457321,722183,042181,853104,366117,78420,000
hp & lease commitments70,46174,10919,09427,05425,15257,41491,30456,57818,133
other current liabilities286,951456,537522,790646,8421,016,018854,924297,372293,171252,595312,367806,246918,003642,205
total current liabilities671,267923,250860,504994,1641,540,7701,324,156775,087678,916554,542715,3411,069,7841,165,7121,117,534436,107292,346
loans186,313312,899456,078394,307407,033237,109420,543335,707431,97478,333
hp & lease commitments93,509173,36319,09246,14757,285102,65332,081
Accruals and Deferred Income33,66448,26971,99382,639103,29968,21681,14595,246108,96889,1338,291
other liabilities16,4919,68527,43130,356
provisions24,92624,92624,92624,92629,63918,92222,01831,86260,64352,98240,62843,01628,01321,00422,998
total long term liabilities354,903559,457562,682548,395616,474324,247523,706520,100704,238252,52948,91943,01628,01321,00422,998
total liabilities1,026,1701,482,7071,423,1861,542,5592,157,2441,648,4031,298,7931,199,0161,258,780967,8701,118,7031,208,7281,145,547457,111315,344
net assets1,053,5461,302,1501,438,9881,972,4042,803,7832,238,2271,874,1271,688,6972,714,6402,616,1852,254,9921,639,2651,257,33766,47553,921
total shareholders funds1,053,5461,302,1501,438,9881,972,4042,803,7832,238,2271,874,1271,688,6972,714,6402,616,1852,254,9921,639,2651,257,33766,47553,921
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Aug 2015Aug 2014Aug 2013Aug 2012Aug 2011Aug 2010Aug 2009
Operating Activities
Operating Profit-254,832-225,373-772,652-851,340685,397104,301183,649-1,279,252-239,150531,693783,110672,804737,70321,45454,864
Depreciation209,324241,038192,538238,191210,438176,925262,42046,158314,008235,366102,35192,58449,97951,296174,752
Amortisation34,54034,54030,10248,577410,162176,087108,130196,600203,181127,427120,90995,031
Tax104,27288,455219,89598,980-20,360219,32125,801194,177317,017-148,175-172,068-264,248-242,615-6,049-15,389
Stock
Debtors-502,433120,258251,510-1,234,951-43,562684,603524,368-368,485-277,241239,621602,23259,868691,175174,669106,973
Creditors-62,15589,959-18,346-67-108,31247,74248,37362,490-237,256101,30315,829-227,62039,222143,761292,346
Accruals and Deferred Income-184,191-89,977-134,698-389,836196,177544,623-9,90026,854-39,937-413,037-103,466275,798642,205
Deferred Taxes & Provisions-4,71310,717-3,096-9,844-28,7817,66112,354-2,38815,0037,009-1,99422,998
Cash flow from operations349,39118,384-734,671374,7431,427,781581,30084,261-413,269602,765207,310142,045599,484542,32833,799422,598
Investing Activities
capital expenditure-242,873-159,566-159,617-538,021-775,988-405,203-258,519-346,872-47,569-398,508
Change in Investments-16,90816,908-5,0015,001-710610100
cash flow from investments16,908-16,9085,001-242,873-164,567-159,617-538,021-775,988-405,203-258,519-346,162-48,179-398,608
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans -16,594-15,97516,698-179,265138,6801,18977,487-13,41897,78420,000
Long term loans-126,586-143,17961,771-12,726169,924-183,43484,836-96,267353,64178,333
Hire Purchase and Lease Commitments-83,502228,378-27,052-25,15371,299-57,414-91,175-10,642109,01750,214
other long term liabilities16,491-9,685-17,746-2,92530,356
share issue-13,8691,49223,127-33,103-22,98761,52837,17755,87549,232-2,03223,975-2,590763,223-3,00014,350
interest-50,776-28,005-21,532-48,841-41,137-38,107-43,809-43,898-28,644-293710-1,938-1,14914996
cash flow from financing-274,83633,02635,266-302,013346,135-216,23864,516-108,350581,030146,22224,685-4,528762,074-2,85114,446
cash and cash equivalents
cash-21,816-335,776-676,540-53,803812,467169,42213,535-423,655444,095-588,957-258,555314,337891,940-17,23138,436
overdraft
change in cash-21,816-335,776-676,540-53,803812,467169,42213,535-423,655444,095-588,957-258,555314,337891,940-17,23138,436

hafren scientific ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for hafren scientific ltd. Get real-time insights into hafren scientific ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Hafren Scientific Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for hafren scientific ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in SY21 area or any other competitors across 12 key performance metrics.

hafren scientific ltd Ownership

HAFREN SCIENTIFIC LTD group structure

Hafren Scientific Ltd has 5 subsidiary companies.

HAFREN SCIENTIFIC LTD Shareholders

timothy pearce 60.02%
john martin 24.01%
sandip jhooty 13.33%
victoria ridge 1.32%
interconsu lt limited 1.32%

hafren scientific ltd directors

Hafren Scientific Ltd currently has 4 directors. The longest serving directors include Dr Carol Bell (Dec 2014) and Ms Victoria Ridge (Oct 2016).

officercountryagestartendrole
Dr Carol BellUnited Kingdom66 years Dec 2014- Director
Ms Victoria RidgeUnited Kingdom49 years Oct 2016- Director
Mr Manjit JhootyUnited Kingdom50 years Dec 2016- Director
Dr Paul CareyEngland58 years Jan 2017- Director

P&L

December 2023

turnover

3.3m

-14%

operating profit

-254.8k

+13%

gross margin

46%

-1.69%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

1.1m

-0.19%

total assets

2.1m

-0.25%

cash

307.9k

-0.07%

net assets

Total assets minus all liabilities

hafren scientific ltd company details

company number

06769895

Type

Private limited with Share Capital

industry

70100 - Activities of head offices

incorporation date

December 2008

age

17

incorporated

UK

ultimate parent company

None

accounts

Group

last accounts submitted

December 2023

previous names

chemostrat international limited (September 2013)

accountant

-

auditor

PRITCHETT & CO BUSINESS ADVISERS LIMITED

address

unit 1 ravencroft court, buttington enterprise park butti, welshpool, powys, SY21 8SL

Bank

-

Legal Advisor

-

hafren scientific ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to hafren scientific ltd. Currently there are 4 open charges and 1 have been satisfied in the past.

hafren scientific ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for HAFREN SCIENTIFIC LTD. This can take several minutes, an email will notify you when this has completed.

hafren scientific ltd Companies House Filings - See Documents

datedescriptionview/download